Arkolith/Insider Trading/MNPR/Form 4

Tsuchimoto Kim R

DirectorMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Jul 16, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$356K
Net Open-Market Flow
-$356K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2025Option exercise(X)9K$0.01$8920K
Jul 14, 2025Sell(S)9K$40.00$356K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 14, 2025Option exercise(X)4K—$00
Jul 14, 2025Option exercise(X)5K—$00

Transaction Codes

X
Exercise of in-the-money derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-022863) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML